Full Text View
Tabular View
Study Results
Related Studies
Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Study NCT00400153   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: November 15, 2006   Last Updated: July 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Chronic Disease
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Respiratory Tract Diseases
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services